TherapeuticsMD (TXMD) Tops Q3 EPS by 2c
TherapeuticsMD (NASDAQ: TXMD) reported Q3 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
TherapeuticsMD (NASDAQ: TXMD) reported Q3 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.